Does RITUXIMAB Cause Basal cell carcinoma? 1,085 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,085 reports of Basal cell carcinoma have been filed in association with RITUXIMAB (Rituxan). This represents 0.6% of all adverse event reports for RITUXIMAB.
1,085
Reports of Basal cell carcinoma with RITUXIMAB
0.6%
of all RITUXIMAB reports
25
Deaths
690
Hospitalizations
How Dangerous Is Basal cell carcinoma From RITUXIMAB?
Of the 1,085 reports, 25 (2.3%) resulted in death, 690 (63.6%) required hospitalization, and 26 (2.4%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 1,085 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
ALENDRONATE (610)
Which RITUXIMAB Alternatives Have Lower Basal cell carcinoma Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE